GT BIOPHARMA INC (GTBP)
US36254L3087 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -7.60M | -20.88M | -58.01M | -28.30M | -38.65M | |||
| Depreciation Amortization | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Change In Working Capital | 1.82M | -1.99M | 7.25M | -600.00K | 2.94M | |||
| Interest Paid | 213.00K | 0.00 | 0.00 | 0.00 | N/A | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |||
| Other non cash items | -3.08M | 7.66M | 35.16M | 21.63M | 32.05M | |||
| OPERATING CASH FLOW | -8.85M | -15.22M | -15.61M | -7.26M | -3.66M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Investing Activity | -2.01M | 12.15M | -23.04M | 0.00 | 200.00K | |||
| INVESTING CASH FLOW | -2.01M | 12.15M | -23.04M | 0.00 | 200.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 1.21M | 12.53M | 3.43M | |||
| Stock Issued/Repurchased | 6.27M | 0.00 | 41.11M | N/A | N/A | |||
| Other Financing Activity | N/A | -220.00K | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 6.27M | -220.00K | 42.32M | 12.53M | 3.43M | |||
| CHANGE IN CASH | -4.59M | -3.29M | 3.67M | 5.27M | -30.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -8.85M | -15.22M | -15.61M | -7.26M | -3.66M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | 0.00 | |||
| FREE CASH FLOW | -8.85M | -15.22M | -15.61M | -7.26M | -3.66M | |||
All data in USD